Understanding BPC-157 Body Protection Compound 157, or BPC-157, is a synthetic substance
Ozempic is a GLP-1 receptor agonist, usually given as a once-weekly injection, which slows stomach emptying, increases feelings of fullness, and affects blood sugar regulation
However, Wegovy is covered in Medicare for other indications such as cardiac disease
G., Chen, R., Thurber, K
Interestingly, the author described a reaction similar to the paradoxical reaction, where some patients experienced a temporary worsening of symptoms including a slight elevation of temperature, weakness, stiffness of muscles and fingers, loss of appetite, buzzing or blowing in ears, and conjunctivitis lasting from several hours to several days